… mean ejection fraction ranged from 29% to 32%. Compared with … patients with chronic HF
diagnoses. The distinction between de novo or recently diagnosed HF and worsening chronic …

… for worsening HF with reduced ejection fraction (EF) and well treated with evidence-based
therapies. Specifically, the objectives of this post-hoc analysis of the EVEREST clinical trial …

… disease trajectory of patients with heart failure (… of worsening HF, yet its prognostic and
clinical relevance, specifically in patient with HF with mildly reduced or preserved ejection fraction …

… patients with chronic symptomatic HFrEF (ejection fraction ≤… to those enrolled in contemporary
heart failure trials. Patients … visit for heart failure or hospitalization for heart failure in the …

… Effect of vericiguat, a soluble guanylate cyclase stimulator, on natriuretic peptide levels in
patients with worsening chronic heart failure and reduced ejection fraction: The SOCRATES-…

… Patients hospitalized for heart failure with reduced ejection fraction (HFrEF) can be divided
into those with de novo heart failure (HF) versus those with worsening chronic heart failure (…

… The goal of this study was to investigate the relationship between WRF and outcomes in
heart failure patients with preserved ejection fraction (HFpEF) and the interaction with RAAS …

… worsening heart failure” (WHF). Despite guideline-directed medical therapy, worsening of
chronic heart failure … risk of death and hospitalization than patients with “stable” HF. New drugs …

… We included in this analysis all consecutive patients with stable congestive heart failure related
… The effect of LVEF deterioration on cardiovascular death was analyzed by univariate Cox …

… of patients with HFpEF with acute heart failure with the following objectives: (1) to describe
the baseline characteristics and co-morbidities of hospitalized urban patients with HFpEF; …